معرفی
Brian Kwee is an Assistant Professor at the University of Delaware, affiliated with the Ammon Pinizzotto Biopharmaceutical Innovation Center. His research focuses on cell and tissue engineering, immunoengineering, and drug delivery systems. He earned a Ph.D. in Bioengineering from Harvard University (2018) and a B.S. in Chemical and Biomolecular Engineering from Cornell University (2012), after completing a postdoctoral fellowship at the FDA (2018-2022).
Dr. Kwee’s work emphasizes enhancing tissue regeneration therapies by modulating immune responses and improving cell manufacturing processes. His lab develops biomaterials to recruit immune cells (e.g., macrophages, T-cells) for pro-regenerative environments and uses fluorescence-activated cell sorting (FACS) to identify optimal cell subpopulations for therapies. Key areas include skeletal muscle repair, vascularized tissue engineering, and immunoengineering for cell-based therapies.
His research trends span biomaterial design, cell manufacturing optimization, and immune-tissue interactions. Notable publications explore functional heterogeneity of mesenchymal stromal cells, engineered microenvironments for cell therapies, and T-cell recruitment for ischemic diseases. Despite no explicitly listed awards, his work aligns with cutting-edge biomedical engineering advancements.
Advising and grants details are not specified in the provided texts. His lab website highlights ongoing projects in microphysiological systems and biomaterial-based therapies.
